{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:05:46Z","timestamp":1761919546756},"reference-count":18,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mutations in the coding region of telomerase complex genes can result in accelerated telomere attrition and human disease. Manifestations of telomere disease include the bone marrow failure syndromes dyskeratosis congenita and aplastic anemia, acute myeloid leukemia, liver cirrhosis, and pulmonary fibrosis. Here, we describe a mutation in the CCAAT box (GCAAT) of the TERC gene promoter in a family in which multiple members had typical features of telomeropathy. The genetic alteration in this critical regulatory sequence resulted in reduced reporter gene activity and absent binding of transcription factor NF-Y, likely responsible for reduced TERC levels, decreased telomerase activity, and short telomeres. This is the first description of a pathogenic mutation in the highly conserved CCAAT box and the first instance of a mutation in the promoter region of TERC producing a telomeropathy. We propose that current mutation-screening strategies should include gene promoter regions for the diagnosis of telomere diseases. This clinical trial was registered at www.clinicaltrials.gov as #NCT00071045.<\/jats:p>","DOI":"10.1182\/blood-2011-10-383182","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T12:10:11Z","timestamp":1328789411000},"page":"3060-3063","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":28,"title":["Human telomere disease due to disruption of the CCAAT box of the TERC promoter"],"prefix":"10.1182","volume":"119","author":[{"given":"Anna M.","family":"Aalbers","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"},{"name":"Department of Pediatric Oncology\/Hematology, Erasmus MC\u2013Sophia Children's Hospital, Rotterdam, The Netherlands;"},{"name":"Department of Immunology, Erasmus MC, Rotterdam, The Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Kajigaya","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus MC\u2013Sophia Children's Hospital, Rotterdam, The Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, Rotterdam, The Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo T.","family":"Calado","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"},{"name":"Department of Internal Medicine, University of S\u00e3o Paulo at Ribeir\u00e3o Preto Medical School, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"24","key":"2019111810212035200_B1","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases.","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"key":"2019111810212035200_B2","volume-title":"The Drug Etiology of Agranulocytosis and Aplastic Anemia","author":"Kaufman","year":"1991"},{"issue":"12","key":"2019111810212035200_B3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2010.1376","article-title":"Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.","volume":"304","author":"Scheinberg","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"2019111810212035200_B4","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR.","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2019111810212035200_B5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcmd.2007.08.002","article-title":"Identification and functional characterization of novel telomerase variant alleles in Japanese patients with bone-marrow failure syndromes.","volume":"40","author":"Takeuchi","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"24","key":"2019111810212035200_B6","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.4161\/cc.8.24.10240","article-title":"A perspective of promoter architecture from the CCAAT box.","volume":"8","author":"Dolfini","year":"2009","journal-title":"Cell Cycle"},{"issue":"5","key":"2019111810212035200_B7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/nar\/26.5.1135","article-title":"A survey of 178 NF-Y binding CCAAT boxes.","volume":"26","author":"Mantovani","year":"1998","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2019111810212035200_B8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.neo.7900114","article-title":"Activation of telomerase RNA gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.","volume":"2","author":"Zhao","year":"2000","journal-title":"Neoplasia"},{"issue":"1-3","key":"2019111810212035200_B9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(03)00038-3","article-title":"Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.","volume":"536","author":"Zhao","year":"2003","journal-title":"FEBS Lett"},{"issue":"5","key":"2019111810212035200_B10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V77.5.1124.1124","article-title":"The Georgia type of nondeletional hereditary persistence of fetal hemoglobin has a C \u2192 T mutation at nucleotide \u2212114 of the Agamma-globin gene.","volume":"77","author":"Oner","year":"1991","journal-title":"Blood"},{"issue":"17","key":"2019111810212035200_B11","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1093\/nar\/18.17.5245","article-title":"A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression.","volume":"18","author":"Fucharoen","year":"1990","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2019111810212035200_B12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/03630269908996160","article-title":"A novel C\u2192A transversion within the distal CCAAT motif of the Ggamma-globin gene in the Algerian Ggammabeta+-hereditary persistence of fetal hemoglobin.","volume":"23","author":"Zertal-Zidani","year":"1999","journal-title":"Hemoglobin"},{"issue":"22","key":"2019111810212035200_B13","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1093\/nar\/16.22.10635","article-title":"Distal CCAAT box deletion in the Agamma globin gene of two black adolescents with elevated fetal Agamma globin.","volume":"16","author":"Gilman","year":"1988","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2019111810212035200_B14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00277-007-0312-8","article-title":"A novel mutation of \u221273(A\u2192T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.","volume":"86","author":"Chen","year":"2007","journal-title":"Ann Hematol"},{"issue":"1","key":"2019111810212035200_B15","first-page":"3","article-title":"A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with paroxysmal nocturnal haemoglobinuria.","volume":"4","author":"Keith","year":"2004","journal-title":"BMC Blood Disord"},{"issue":"5","key":"2019111810212035200_B16","first-page":"707","article-title":"TERC mutations in children with refractory cytopenia.","volume":"91","author":"Ortmann","year":"2006","journal-title":"Haematologica"},{"issue":"13","key":"2019111810212035200_B17","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2006-12-062851","article-title":"Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.","volume":"110","author":"Marrone","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2019111810212035200_B18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jmg.2011.089821","article-title":"Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations.","volume":"48","author":"Tsangaris","year":"2011","journal-title":"J Med Genet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/13\/3060\/1348845\/zh801312003060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/13\/3060\/1348845\/zh801312003060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T15:57:58Z","timestamp":1574092678000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/13\/3060\/29628\/Human-telomere-disease-due-to-disruption-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":18,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-383182","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}